Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström Pet al.(2023) Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden BMJ Open, 13(3), e070071 DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
Arous D, Lie JL, Håland BV, Børsting M, Edin NFJ, Malinen E(2023) 2D mapping of radiation dose and clonogenic survival for accurate assessment ofin vitroX-ray GRID irradiation effects Phys Med Biol, 68(2) DOI 10.1088/1361-6560/acaf20, PubMed 36580679
Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD(2022) Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy J Cancer Surviv, 1-12(in press) DOI 10.1007/s11764-022-01273-1, PubMed 36350483